Well in my opinion your description that is a cancer rings very true.

Especially where one would think that the price would normally be building on speculation before the expected news release and then would obtain the expected drop in price.

It seems that with the $100.00 cancer, they are succeeding in doing a double whammy to engineer a drop in price during the pre-news release period as well as during the after news release period. It sure does look like manipulation.

Lets hope this doesn't hold true.